39 results on '"Akampurira, Andrew"'
Search Results
2. Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial
3. 829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin
4. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
5. Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
6. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Substudy of the EnACT Trial Testing Oral Amphotericin.
7. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
8. Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda
9. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
10. Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial
11. 869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial
12. Cryptococcus neoformans Ex Vivo Capsule Size Is Associated With Intracranial Pressure and Host Immune Response in HIV-associated Cryptococcal Meningitis
13. Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis
14. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality.
15. ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50
16. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials
17. Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda
18. ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50.
19. Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection
20. The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence
21. Identification of pathogen genomic differences that impact human immune response and disease duringCryptococcus neoformansinfection
22. Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection
23. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda
24. Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid.
25. Epidemiology of Meningitis in an HIV-Infected Ugandan Cohort
26. Antimicrobial Resistance in Uganda and the Urgent Need for Standardized Reporting and a National Surveillance Program
27. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
28. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.
29. 1432Diagnostic Performance of a Multiplex PCR Assay for Meningitis in an HIV-Infected Population in Uganda
30. 1472Epidemiology of Meningitis in an HIV-infected Ugandan Cohort
31. Cryptococcus neoformans Ex Vivo Capsule Size Is Associated With Intracranial Pressure and Host Immune Response in HIV-associated Cryptococcal Meningitis
32. Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.
33. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformansin Uganda
34. Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting.
35. The Mouse Inhalation Model of Cryptococcus neoformansInfection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence
36. Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings.
37. Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal Meningitis.
38. In Vitro Evaluation of the Virulence Attributes of Oropharyngeal Candida Species Isolated from People Living with Human Immunodeficiency Virus with Oropharyngeal Candidiasis on Antiretroviral Therapy.
39. Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.